118 related articles for article (PubMed ID: 1648035)
1. Synthesis and characterization of [186Re]rhenium(V)dimercaptosuccinic acid: a possible tumour radiotherapy agent.
Bisunadan MM; Blower PJ; Clarke SE; Singh J; Went MJ
Int J Rad Appl Instrum A; 1991; 42(2):167-71. PubMed ID: 1648035
[TBL] [Abstract][Full Text] [Related]
2. Studies on the preparation and isomeric composition of 186Re- and 188Re-pentavalent rhenium dimercaptosuccinic acid complex.
Singh J; Reghebi K; Lazarus CR; Clarke SE; Callahan AP; Knapp FF; Blower PJ
Nucl Med Commun; 1993 Mar; 14(3):197-203. PubMed ID: 8384352
[TBL] [Abstract][Full Text] [Related]
3. Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies.
Blower PJ; Lam AS; O'Doherty MJ; Kettle AG; Coakley AJ; Knapp FF
Eur J Nucl Med; 1998 Jun; 25(6):613-21. PubMed ID: 9618576
[TBL] [Abstract][Full Text] [Related]
4. Carrier effect on radiolabeling the polynuclear pentavalent rhenium-186 complex of dimercaptosuccinic acid at alkaline pH: 186Re(V)-DMS.
Horiuchi K; Saji H; Yokoyama A
Nucl Med Biol; 1999 Oct; 26(7):771-9. PubMed ID: 10628556
[TBL] [Abstract][Full Text] [Related]
5. Preparation of [186Re]Re-DMSA and its bio-distribution studies.
Kothari K; Pillai MR; Unni PR; Shimpi HH; Noronha OP; Samuel AM
Appl Radiat Isot; 1999 Jul; 51(1):43-9. PubMed ID: 10376320
[TBL] [Abstract][Full Text] [Related]
6. An alternative approach to the preparation of (188)Re radiopharmaceuticals from generator-produced [(188)ReO(4)](-): efficient synthesis of (188)Re(V)-meso-2,3-dimercaptosuccinic acid.
Bolzati C; Boschi A; Uccelli L; Duatti A; Franceschini R; Piffanelli A
Nucl Med Biol; 2000 Apr; 27(3):309-14. PubMed ID: 10832088
[TBL] [Abstract][Full Text] [Related]
7. Reliable preparation of 99mTc (V) DMSA by a simple modified method using a commercial kit for 99mTc (III) DMSA.
Washburn LC; Biniakiewicz DS; Maxon HR
Nucl Med Biol; 1995 Jul; 22(5):689-91. PubMed ID: 7581181
[TBL] [Abstract][Full Text] [Related]
8. Comparison of chromatographic methods for quality control of DMSA complexes with 99mTc and 188Re at (III) and (V) oxidation states.
Garnuszek P; Pawlak D; Maurin M; Jankovic D; Karczmarczyk U; Mikołajczak R
Nucl Med Rev Cent East Eur; 2012 Aug; 15(2):95-100. PubMed ID: 22936501
[TBL] [Abstract][Full Text] [Related]
9. 188Rhenium(V)-dimercaptosuccinic acid loaded poly(lactic-co-glycolic)acid microspheres for targeted radiotherapy: production and effectivity.
Shukla J; Bandopadhyaya GP; Varma IK
Pharmazie; 2005 Aug; 60(8):583-7. PubMed ID: 16124400
[TBL] [Abstract][Full Text] [Related]
10. 99mTc(V)DMSA quantitatively predicts 188Re(V)DMSA distribution in patients with prostate cancer metastatic to bone.
Blower PJ; Kettle AG; O'Doherty MJ; Coakley AJ; Knapp FF
Eur J Nucl Med; 2000 Sep; 27(9):1405-9. PubMed ID: 11007525
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a DMSA kit for instant preparation of 99mTc(V)-DMSA for tumour and metastasis scintigraphy.
Chauhan UP; Babbar A; Kashyap R; Prakash R
Int J Rad Appl Instrum B; 1992 Nov; 19(8):825-30. PubMed ID: 1330991
[TBL] [Abstract][Full Text] [Related]
12. 99mTechnetium(V) dimercaptosuccinic acid (99mTc(v) DMSA) as a tumour seeking agent in nasopharyngeal carcinoma.
Aw SE; Sundram FX; Goh AS
Ann Acad Med Singap; 1986 Oct; 15(4):498-501. PubMed ID: 3032068
[TBL] [Abstract][Full Text] [Related]
13. Preparation and evaluation of 99mTc(V)-DMSA complex: studies in medullary carcinoma of thyroid.
Ramamoorthy N; Shetye SV; Pandey PM; Mani RS; Patel MC; Patel RB; Ramanathan P; Krishna BA; Sharma SM
Eur J Nucl Med; 1987; 12(12):623-8. PubMed ID: 3034614
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of tumour imaging using 99Tc(V)m dimercaptosuccinic acid, a new tumour-seeking agent.
Ohta H; Endo K; Fujita T; Konishi J; Torizuka K; Horiuchi K; Yokoyama A
Nucl Med Commun; 1988 Feb; 9(2):105-16. PubMed ID: 2838772
[TBL] [Abstract][Full Text] [Related]
15. A convenient method for the preparation of 99mTc-labelled pentavalent DMSA and its evaluation as a tumour imaging agent.
Babbar A; Kashyap R; Chauhan UP
J Nucl Biol Med (1991); 1991; 35(2):100-4. PubMed ID: 1657203
[TBL] [Abstract][Full Text] [Related]
16. Preparation and biological characterization of isomeric 188Re(V) oxocomplexes with tetradentate S4 ligands derived from meso-dimercaptosuccinic acid for labeling of biomolecules.
Seifert S; Heinrich T; Jentschel C; Smuda C; Bergmann R; Pietzsch HJ
Bioconjug Chem; 2006; 17(6):1601-6. PubMed ID: 17105241
[TBL] [Abstract][Full Text] [Related]
17. Rhenium-188: availability from the (188)W/(188)Re generator and status of current applications.
Pillai MR; Dash A; Knapp FF
Curr Radiopharm; 2012 Jul; 5(3):228-43. PubMed ID: 22642385
[TBL] [Abstract][Full Text] [Related]
18. Uptake of the 188Re(V)-DMSA complex by cervical carcinoma cells in nude mice: pharmacokinetics and dosimetry.
García-Salinas L; Ferro-Flores G; Arteaga-Murphy C; Pedraza-López M; Hernández-Gutiérrez S; Azorin-Nieto J
Appl Radiat Isot; 2001 Mar; 54(3):413-8. PubMed ID: 11214875
[TBL] [Abstract][Full Text] [Related]
19. Preparation and clinical evaluation of technetium-99m dimercaptosuccinic acid for tumour scintigraphy.
Hirano T; Tomiyoshi K; Zhang YJ; Ishida T; Inoue T; Endo K
Eur J Nucl Med; 1994 Jan; 21(1):82-5. PubMed ID: 8088289
[TBL] [Abstract][Full Text] [Related]
20. 188Re(V)-DMSA revisited: preparation and biodistribution of a potential radiotherapeutic agent with low kidney uptake.
Dadachova E; Chapman J
Nucl Med Commun; 1998 Feb; 19(2):173-81. PubMed ID: 9548202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]